Gufic Biosciences Limited (BOM:509079)

Gufic Biosciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	621.86	157.23	11.37	286.02	116.08
Cash & Short-Term Investments	621.86	621.86	157.23	11.37	286.02	116.08
Cash Growth	114.27%	295.50%	1283.12%	-96.03%	146.40%	87.18%
Accounts Receivable	-	2,974	3,146	3,299	2,055	1,516
Other Receivables	-	15.71	15.71	-	-	-
Receivables	-	2,996	3,165	3,303	2,057	1,519
Inventory	-	3,245	2,169	2,005	1,835	1,156
Prepaid Expenses	-	18.47	13.11	8.61	9.5	8.51
Other Current Assets	-	1,140	741.2	676.9	454.29	407.93
Total Current Assets	-	8,021	6,245	6,005	4,641	3,208
Property, Plant & Equipment	-	5,070	5,215	4,603	3,285	1,554
Long-Term Investments	-	17.84	17.84	17.84	7.84	0.08
Other Intangible Assets	-	61.64	63.44	56.19	6.79	6.1
Long-Term Deferred Tax Assets	-	-	-	-	9.66	-
Other Long-Term Assets	-	247.91	150.33	239.13	658.02	443.58
Total Assets	-	13,424	11,694	10,925	8,612	5,214

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	1,990	1,587	1,663	1,303	1,410
Accrued Expenses	-	213.29	197.36	184.07	143.78	172.45
Short-Term Debt	-	2,545	1,543	1,420	1,118	65.99
Current Portion of Long-Term Debt	-	256.76	256.08	210.54	89.67	66.65
Current Portion of Leases	-	52.18	62.27	43.26	65.76	28.17
Current Income Taxes Payable	-	18.61	-	25.45	31.24	6.75
Other Current Liabilities	-	102.86	229.7	174.31	131.37	114.5
Total Current Liabilities	-	5,178	3,876	3,720	2,882	1,864
Long-Term Debt	-	1,050	1,305	1,540	1,907	479.78
Long-Term Leases	-	143.73	195.93	115.55	162.1	3.29
Pension & Post-Retirement Benefits	-	108.77	105.32	90.59	77.75	65.88
Long-Term Deferred Tax Liabilities	-	165.74	77.72	20.63	-	1.9
Other Long-Term Liabilities	-	126.79	123.34	112.92	104.8	107.98
Total Liabilities	-	6,774	5,683	5,600	5,134	2,523

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	100.28	100.28	100.28	96.95	96.95
Additional Paid-In Capital	-	998.31	996.57	996.57	-	-
Retained Earnings	-	4,856	4,223	3,538	2,686	1,899
Comprehensive Income & Other	-	694.44	690.49	690.72	694.76	695.22
Total Common Equity	6,649	6,649	6,011	5,326	3,478	2,691
Minority Interest	-	0.38	-	-	-	-
Shareholders' Equity	6,650	6,650	6,011	5,326	3,478	2,691
Total Liabilities & Equity	-	13,424	11,694	10,925	8,612	5,214

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	4,048	4,048	3,362	3,329	3,342	643.87
Net Cash (Debt)	-3,426	-3,426	-3,205	-3,318	-3,056	-527.79
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-34.16	-34.16	-31.96	-33.68	-31.52	-5.44
Filing Date Shares Outstanding	100.51	100.28	100.28	100.28	96.94	96.94
Total Common Shares Outstanding	100.51	100.28	100.28	100.28	96.94	96.94
Working Capital	-	2,843	2,370	2,284	1,759	1,344
Book Value Per Share	66.31	66.31	59.94	53.11	35.88	27.76
Tangible Book Value	6,588	6,588	5,947	5,269	3,471	2,685
Tangible Book Value Per Share	65.69	65.69	59.31	52.55	35.81	27.70
Land	-	103.9	103.9	98.9	-	-
Buildings	-	1,235	1,230	383.55	417.59	355.81
Machinery	-	4,316	4,167	1,516	1,534	1,229
Construction In Progress	-	221.45	218.16	3,071	1,696	408.74

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error